A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.
Market Scope
Trusted Partner of Industry and Medical Professionals for Market Data, Independent Perspective, & Objective Analysis
Latest Reports Latest News
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Physician Surveys
For 20+ years, we have surveyed physicians to provide both physicians & industry professionals unbiased insight into the market.
Complete a Survey
On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.
Benchmark Your Performance
Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.
View Market Insights & Analytics
Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.
Learn More Register Today
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 1
Interview With Scendia Biologics
- 7
News Briefs
- 5
Top Stories of 2019
- 49
Monthly 510(k) Clearances
Latest Industry News & Trends
1/17/2020
BreakingFundingOphthalmicPharmaRetina
Apellis Raises $404.2 Million in Public Offering
Apellis Pharmaceuticals, now of Waltham, Massachusetts, announced Jan. 14 that it had raised $404.2 million in gross proceeds from an underwritten public offering of common stock, including the ful...
1/17/2020
BreakingGene TherapyOphthalmicRegulationRetina
FDA Lifts Clinical Hold on Regenxbio’s Gene Therapy Candidate for Wet AMD
Gene therapy company Regenxbio reported Jan. 9 that the FDA has removed a partial clinical hold on its Phase I/IIa trial of subretinal delivery of RGX-314 for wet age-related macular degeneration w...
1/17/2020
BreakingCataractOphthalmicRegulationSurgical
STAAR Gains Supplemental Lens Approval for EVO Visian ICL in Post-Cataract Patients
STAAR Surgical has gained CE marking for use of its implantable collamer lenses (ICL) as a supplemental or “piggyback” lens in post-cataract surgery patients, the company announced Jan. 13. A suppl...
1/17/2020
BreakingDealsOphthalmicPharmaRetina
Exonate Teams with Janssen to Develop Eye Drop for Wet AMD, DME
Exonate, of Cambridge, England, has entered into a strategic collaboration agreement with Janssen Pharmaceuticals to develop an eye drop treatment for retinal vascular diseases, the company announc...
1/17/2020
BreakingDiagnosticOphthalmicRegulation
CPT Codes Established for Home OCT Use
The American Medical Association’s Current Procedural Terminology (CPT) panel has established three new Category III codes (0604T, 0605T, 0606T) to report patient-initiated remote retinal optical c...
1/17/2020
NewsletterOrthopedic
Medtronic Issues Field Safety Notice for Mazor X Positioner
Medtronic issued a field safety notice Jan. 7 for its Mazor X surgical system with Positioner Type II latching device. The positioner, which locks onto the OR table through a pneumatic system, may ...
1/17/2020
NewsletterOrthopedic
Exactech Names Johnson New CEO
Exactech, a Florida-based orthopedic implant company with solutions for extremities, knees, and hips, announced Jan. 7 that Darin Johnson will be taking David Petty’s place as president and CEO. Pe...
1/17/2020
BreakingDealsOphthalmicPharmaRetina
Coherus Acquires Commercial Rights for Avastin Biosimilar in the US
Coherus BioSciences has entered into a licensing agreement with Innovent Biologics of China to commercialize Innovent’s biosimilar candidate to Avastin (bevacizumab) in the US and Canada, the compa...
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.